Invention Grant
- Patent Title: Pharmaceutical composition for treating hepatitis, liver fibrosis, and liver cancer
-
Application No.: US16087624Application Date: 2017-03-24
-
Publication No.: US10729713B2Publication Date: 2020-08-04
- Inventor: Ruizhi Zhao , Ya Zhao , Lijuan Liu
- Applicant: GUANGDONG PROVINCIAL HOSPITAL OF CHINESE MEDICINE
- Applicant Address: CN Guangzhou, Guangdong
- Assignee: GUANGDONG PROVINCIAL HOSPITAL OF CHINESE MEDICINE
- Current Assignee: GUANGDONG PROVINCIAL HOSPITAL OF CHINESE MEDICINE
- Current Assignee Address: CN Guangzhou, Guangdong
- Agency: Global IP Services
- Agent Tianhua Gu
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@4f8ca8e5
- International Application: PCT/CN2017/078050 WO 20170324
- International Announcement: WO2017/181816 WO 20171026
- Main IPC: A61K36/233
- IPC: A61K36/233 ; A61K31/715 ; A61K31/4375 ; A61P35/00 ; A61P1/16
Abstract:
The present invention relates to a pharmaceutical composition for treating hepatitis, liver fibrosis, and liver cancer, which comprises the following components in parts by weight: 0.15-10 parts of vinegar-baked bupleurum root polysaccharides or bupleurum root polysaccharides and 0.05-5 parts of a drug for treating hepatitis.
Public/Granted literature
- US20190099439A1 PHARMACEUTICAL COMPOSITION FOR TREATING HEPATITIS, LIVER FIBROSIS, AND LIVER CANCER Public/Granted day:2019-04-04
Information query
